Search in:

Clinical, Cosmetic and Investigational Dermatology Volume 10, 2017 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Review

Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy

Zoe Apalla1 First Department of Dermatology, Aristotle UniversityCorrespondence[email protected]

Chrysoula Papageorgiou1 First Department of Dermatology, Aristotle University

Aimilios Lallas1 First Department of Dermatology, Aristotle University

Elena Sotiriou1 First Department of Dermatology, Aristotle University

Elizabeth Lazaridou1 First Department of Dermatology, Aristotle University

Efstratios Vakirlis1 First Department of Dermatology, Aristotle University

Athanassios Kyrgidis2 Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Aristotle University, Thessaloniki, Greece

Demetrios Ioannides1 First Department of Dermatology, Aristotle University

show all

Pages 171-177 | Published online: 10 May 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (18)

Austin R Swisher, Mark J Landau, Allison B Davila, Armando A Davila, Caryn Zagaynov, Christopher A Bobbitt, Darren S Leong, Alexander Y Chang & Walter T Chang. (2022) Non-surgical Management of Locally Advanced Basal Cell Carcinoma of the Upper Extremity With Vismodegib. Cureus.
Crossref

J. Kurnia Wijaya, K. Djawad, S. Wahab, A. Nurdin & A. Irawan Anwar. (2022) [Translated article] Vismodegib and Sonidegib in Locally Advanced and Metastatic Basal Cell Carcinoma: Update on Hedgehog Pathway Inhibitors. Actas Dermo-Sifiliográficas 113:5, pages T443-T450.
Crossref

J. Kurnia Wijaya, K. Djawad, S. Wahab, A. Nurdin & A. Irawan Anwar. (2022) Vismodegib y sonidegib en el carcinoma de células basales localmente avanzado y metastásico: actualización acerca de los inhibidores de la vía de Hedgehog. Actas Dermo-Sifiliográficas 113:5, pages 443-450.
Crossref

Justin Tong, Brandon Mitchell, Kathryn Roth, Diane Logan & Scott Ernst. (2021) Real-World Experience of Vismodegib in Advanced Basal Cell Carcinoma at a Canadian Cancer Center. Journal of Cutaneous Medicine and Surgery 26:2, pages 143-148.
Crossref

Christina Fotiadou, Zoe Apalla & Elizabeth Lazaridou. (2021) Basosquamous Carcinoma: A Commentary. Cancers 13:23, pages 6146.
Crossref

Sofia‐Magdalini Manoli, Andreas Moutsoudis, Chryssoula Papageorgiou, Konstantinos Lallas, Haris‐Marios Rigas, Eirini Kyrmanidou, Ilias Papadimitriou, Eleni Paschou, Ioannis Spyridis, Theodosia Gkentsidi, Elena Sotiriou, Efstratios Vakirlis, Demetrios Ioannidis, Zoe Apalla & Aimilios Lallas. (2020) Real‐life data on basal cell carcinoma treatment: Insights on clinicians' therapeutic choices from an institutional hospital registry. Dermatologic Therapy 33:6.
Crossref

Maxwell G. Su, Luke B. Potts & Jonathan H. Tsai. (2020) Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib. American Journal of Ophthalmology Case Reports 19, pages 100755.
Crossref

James Randall PatrinelyJrJr, Anna K. Dewan & Douglas B. Johnson. (2020) The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer. BioDrugs 34:4, pages 495-503.
Crossref

Carlos A. Torres-Cabala, Michael T. Tetzlaff, Priyadharsini Nagarajan, Doina Ivan, Jonathan L. Curry, Phyu P. Aung & Victor G. Prieto. 2020. Oncological Surgical Pathology. Oncological Surgical Pathology 3 227 .

Ana Filipe Monteiro, Margarida Rato, Miguel Trigo & César Martins. (2019) Aggressive Inferior Eyelid Basal Cell Carcinoma: Advantage of Neoadjuvant Vismodegib. Actas Dermo-Sifiliográficas (English Edition) 110:10, pages 863-865.
Crossref

A.F. Monteiro, M. Rato, M. Trigo & C. Martins. (2019) Carcinoma basocelular agresivo del párpado inferior: ventaja del vismodegib neoadyuvante. Actas Dermo-Sifiliográficas 110:10, pages 863-865.
Crossref

G. Gualdi, R. Moro, V. Regina, S. Caravello, P. Monari & P.G. Calzavara‐Pinton. (2019) PRISModegib: the use of the PRISM test to assess the health‐related quality of life of patients with locally advanced basal cell carcinoma undergoing Hedgehog pathway inhibitor therapy. British Journal of Dermatology 181:2, pages 406-407.
Crossref

Takao Oda, Hiroshi Kato, Shoichi Watanabe & Akimichi Morita. (2019) Facial site distribution of basal cell carcinoma in Japanese. Experimental Dermatology 28, pages 69-71.
Crossref

Richard L. Carpenter & Haimanti Ray. (2019) Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer. Drug Safety 42:2, pages 263-279.
Crossref

James E. Frampton & Nicole Basset-Séguin. (2018) Vismodegib: A Review in Advanced Basal Cell Carcinoma. Drugs 78:11, pages 1145-1156.
Crossref

David J. Duffy, Christine Schnitzler, Lorraine Karpinski, Rachel Thomas, Jenny Whilde, Catherine Eastman, Calvin Yang, Aleksandar Krstic, Devon Rollinson, Bette Zirkelbach, Kelsey Yetsko, Brooke Burkhalter & Mark Q. Martindale. (2018) Sea turtle fibropapilloma tumors share genomic drivers and therapeutic vulnerabilities with human cancers. Communications Biology 1:1.
Crossref

Brian B. Hughley & Cecelia E. Schmalbach. (2018) Cutaneous Head and Neck Malignancies in the Elderly. Clinics in Geriatric Medicine 34:2, pages 245-258.
Crossref

Neha Chandan & Stephanie Wang. (2018) Large Nodular Growth on the Nose. Journal of the Dermatology Nurses' Association 10:1, pages 57-58.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy

Articles from other publishers (18)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy

Citations (18)

Articles from other publishers (18)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date